Forbes acquires Reducol rights from Novartis Consumer Health
Health science company Forbes Medi-Tech Inc. announced this week that it has reached an agreement with Novartis Consumer Health SA to acquire the licensing and distribution rights to consumer products fortified with Reducol, the company's proprietary...